-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
Author: Shi Bei
On October 12, the official website of the State Administration of Food and Drug Administration showed that Tilavancin Hydrochloride (former name: Telavancin) for injection by Saisheng Pharmaceutical/Theravance was declared for listing in China
Telavancin is a lipoglycopeptide antibiotic once a day.
Tilavancin has a dual antibacterial action mechanism.
In May 2015, Saisheng Pharmaceutical and Theravance reached an agreement to obtain the exclusive right to develop and commercialize Vibativ in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and Vietnam
According to the prospectus of Saisheng Pharmaceutical, the market size of anti-MRSA antibacterial drugs in China in 2019 is RMB 4.